|
Volumn 8, Issue 13, 2002, Pages 1155-1172
|
Comprehensive essential gene identification as a platform for novel antiinfective drug discovery
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOTRIAZOLE;
AMPHOTERICIN B;
AMPHOTERICIN B LIPID COMPLEX;
ANTIBIOTIC AGENT;
ANTIFUNGAL AGENT;
ANTIINFECTIVE AGENT;
CASPOFUNGIN;
COMPLEMENTARY RNA;
ECHINOCANDIN B;
FLUCONAZOLE;
METICILLIN;
SORDARIN DERIVATIVE;
TUNICAMYCIN;
VANCOMYCIN;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIBIOTIC RESISTANCE;
CANDIDA ALBICANS;
CELL ASSAY;
CONTROLLED STUDY;
DRUG DETERMINATION;
DRUG RESEARCH;
DRUG SCREENING;
DRUG TARGETING;
ENTEROCOCCUS FAECALIS;
ESSENTIAL GENE;
GENE DISRUPTION;
GENE FUNCTION;
GENE IDENTIFICATION;
GENE TECHNOLOGY;
GENETIC TRANSCRIPTION;
INFECTION;
MOUSE;
NONHUMAN;
PLASMID;
PRIORITY JOURNAL;
PROMOTER REGION;
REVIEW;
STAPHYLOCOCCUS AUREUS;
ANTI-INFECTIVE AGENTS;
DRUG DESIGN;
DRUG INDUSTRY;
DRUG RESISTANCE, MICROBIAL;
GENES, ESSENTIAL;
GENOME, BACTERIAL;
GENOME, FUNGAL;
SACCHAROMYCES CEREVISIAE;
|
EID: 0036265773
PISSN: 13816128
EISSN: None
Source Type: Journal
DOI: 10.2174/1381612023394818 Document Type: Review |
Times cited : (55)
|
References (53)
|